Adjuvant interferon in high-risk melanoma: end of the era?
- PMID: 19949007
- DOI: 10.1200/JCO.2009.24.9326
Adjuvant interferon in high-risk melanoma: end of the era?
Comment on
-
Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group.J Clin Oncol. 2009 Jun 20;27(18):2916-23. doi: 10.1200/JCO.2008.20.2069. Epub 2009 May 11. J Clin Oncol. 2009. PMID: 19433686 Clinical Trial.